PyInvesting

Market research

MED MEDIFAST INC

NYSE USD Consumer Cyclical

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
134M
P/E ratio
Not available
Analyst target
12
Dividend yield
Not available
Beta
0.7

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 4 months ago

Medifast, Inc is currently in a long term uptrend where the price is trading 21.1% above its 200 day moving average.

From a valuation standpoint, the stock is 97.0% cheaper than other stocks from the Consumer Cyclical sector with a price to sales ratio of 2.8.

Medifast, Inc's total revenue rose by 55.3% to $265M since the same quarter in the previous year.

Its net income has increased by 40.8% to $28M since the same quarter in the previous year.

Finally, its free cash flow fell by 2.9% to $18M since the same quarter in the previous year.

Based on the above factors, Medifast, Inc gets an overall score of 4/5.